T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$152B
| $3.88B | 0.57% |
92,853,051
+14,242,558
| +18% | +$548M |
|
27
Roper Technologies
ROP
$39.5B
| $3.87B | 0.56% |
13,066,437
-871,565
| -6% | -$257M |
|
28
Philip Morris
PM
$290B
| $3.71B | 0.54% |
45,556,675
+1,252,690
| +3% | +$103M |
|
|
FISV
29
Fiserv Inc
FISV
$28B
| $3.67B | 0.54% |
44,597,280
-5,886,673
| -12% | -$462M |
|
|
SCHW
30
Charles Schwab
SCHW
$186B
| $3.62B | 0.53% |
73,621,062
+7,439,241
| +11% | +$380M |
|
31
PayPal
PYPL
$50.5B
| $3.58B | 0.52% |
40,731,811
-4,920,402
| -11% | -$433M |
|
32
Morgan Stanley
MS
$338B
| $3.57B | 0.52% |
76,614,866
-10,784,784
| -12% | -$527M |
|
33
Merck
MRK
$322B
| $3.57B | 0.52% |
52,695,966
+8,031,751
| +18% | +$512M |
|
34
ExxonMobil
XOM
$657B
| $3.54B | 0.52% |
41,668,670
+5,439,082
| +15% | +$445M |
|
|
RHT
35
DELISTED
Red Hat Inc
RHT
| $3.5B | 0.51% |
25,677,960
+7,594,813
| +42% | +$1.09B |
|
36
Thermo Fisher Scientific
TMO
$224B
| $3.46B | 0.51% |
14,195,415
+2,555,183
| +22% | +$588M |
|
37
Fidelity National Information Services
FIS
$22.1B
| $3.42B | 0.5% |
31,391,517
+932,733
| +3% | +$101M |
|
|
38
Northrop Grumman
NOC
$81.8B
| $3.39B | 0.49% |
10,674,781
+5,475,285
| +105% | +$1.67B |
|
39
Fortive
FTV
$18.6B
| $3.29B | 0.48% |
61,956,977
+1,902,049
| +3% | +$97.5M |
|
40
Danaher
DHR
$146B
| $3.18B | 0.46% |
33,062,793
-9,702,081
| -23% | -$884M |
|
41
Honeywell
HON
$72.9B
| $3.18B | 0.46% |
21,133,416
+4,346,666
| +26% | +$616M |
|
42
Chubb
CB
$134B
| $3.16B | 0.46% |
23,625,592
+1,696,310
| +8% | +$229M |
|
|
43
NVIDIA
NVDA
$5.27T
| $3.1B | 0.45% |
441,456,560
+379,939,840
| +618% | +$2.47B |
|
|
MRSH
44
Marsh
MRSH
$91.3B
| $3.1B | 0.45% |
37,424,619
-3,222,228
| -8% | -$273M |
|
|
WP
45
DELISTED
Worldpay, Inc.
WP
| $3.09B | 0.45% |
30,470,008
+2,720,697
| +10% | +$248M |
|
46
Dollar General
DG
$26.5B
| $3.03B | 0.44% |
27,711,664
-3,142,345
| -10% | -$327M |
|
|
ALXN
47
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.9B | 0.42% |
20,870,140
-1,180,688
| -5% | -$148M |
|
48
Sempra
SRE
$55.9B
| $2.89B | 0.42% |
50,845,684
+5,302,092
| +12% | +$307M |
|
49
Workday
WDAY
$44.8B
| $2.87B | 0.42% |
19,660,082
-1,432,858
| -7% | -$199M |
|
|
50
Texas Instruments
TXN
$257B
| $2.85B | 0.42% |
26,522,102
-16,343,219
| -38% | -$1.82B |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.